de Charles Schwab National Healthcare NHC Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 36.8 M | Vender |
174,335
-4,263
| -2% | -USD 783 k | ﹤0.01% | 1446 |
|
|
2026
Q1 | USD 28.5 M | Vender |
178,598
-7,451
| -4% | -USD 1.14 M | ﹤0.01% | 1521 |
|
|
2025
Q4 | USD 25.5 M | Vender |
186,049
-2,951
| -2% | -USD 381 k | ﹤0.01% | 1596 |
|
|
2025
Q3 | USD 23 M | Comprar |
189,000
+6,348
| +3% | +USD 685 k | ﹤0.01% | 1652 |
|
|
2025
Q2 | USD 19.5 M | Vender |
182,652
-6,689
| -4% | -USD 669 k | ﹤0.01% | 1684 |
|
|
2025
Q1 | USD 17.6 M | Vender |
189,341
-5,040
| -3% | -USD 488 k | ﹤0.01% | 1699 |
|
|
2024
Q4 | USD 20.9 M | Vender |
194,381
-1,157
| -0.6% | -USD 141 k | ﹤0.01% | 1679 |
|
|
2024
Q3 | USD 24.6 M | Vender |
195,538
-7,109
| -4% | -USD 894 k | ﹤0.01% | 1580 |
|
|
2024
Q2 | USD 22 M | Comprar |
202,647
+5,995
| +3% | +USD 584 k | ﹤0.01% | 1613 |
|
|
2024
Q1 | USD 18.6 M | Vender |
196,652
-2,663
| -1% | -USD 252 k | ﹤0.01% | 1655 |
|
|
2023
Q4 | USD 18.4 M | Comprar |
199,315
+25,193
| +14% | +USD 1.93 M | ﹤0.01% | 1641 |
|
|
2023
Q3 | USD 11.1 M | Comprar |
174,122
+25,925
| +17% | +USD 1.66 M | ﹤0.01% | 1861 |
|
|
2023
Q2 | USD 9.16 M | Comprar |
148,197
+25,172
| +20% | +USD 1.49 M | ﹤0.01% | 1946 |
|
|
2023
Q1 | USD 7.14 M | Comprar |
123,025
+25,112
| +26% | +USD 1.44 M | ﹤0.01% | 2036 |
|
|
2022
Q4 | USD 5.83 M | Comprar |
97,913
+1,063
| +1% | +USD 64.4 k | ﹤0.01% | 2139 |
|
|
2022
Q3 | USD 6.14 M | Comprar |
96,850
+2,034
| +2% | +USD 141 k | ﹤0.01% | 2111 |
|
|
2022
Q2 | USD 6.63 M | Vender |
94,816
-1,717
| -2% | -USD 120 k | ﹤0.01% | 2058 |
|
|
2022
Q1 | USD 6.78 M | Vender |
96,533
-65,026
| -40% | -USD 4.37 M | ﹤0.01% | 2136 |
|
|
2021
Q4 | USD 11 M | Comprar |
161,559
+6,137
| +4% | +USD 425 k | ﹤0.01% | 1956 |
|
|
2021
Q3 | USD 10.9 M | Comprar |
155,422
+11,394
| +8% | +USD 829 k | ﹤0.01% | 1956 |
|
|
2021
Q2 | USD 10.1 M | Comprar |
144,028
+9,440
| +7% | +USD 686 k | ﹤0.01% | 1998 |
|
|
2021
Q1 | USD 10.5 M | Comprar |
134,588
+5,434
| +4% | +USD 385 k | ﹤0.01% | 1939 |
|
|
2020
Q4 | USD 8.58 M | Comprar |
129,154
+13,787
| +12% | +USD 908 k | ﹤0.01% | 1946 |
|
|
2020
Q3 | USD 7.19 M | Comprar |
115,367
+12,302
| +12% | +USD 770 k | ﹤0.01% | 1882 |
|
|
2020
Q2 | USD 6.54 M | Vender |
103,065
-43,069
| -29% | -USD 2.89 M | ﹤0.01% | 1899 |
|
|
2020
Q1 | USD 10.5 M | Comprar |
146,134
+32,925
| +29% | +USD 2.6 M | 0.01% | 1420 |
|
|
2019
Q4 | USD 9.8 M | Comprar |
113,209
+9,090
| +9% | +USD 760 k | 0.01% | 1675 |
|
|
2019
Q3 | USD 8.52 M | Comprar |
104,119
+10,308
| +11% | +USD 853 k | 0.01% | 1693 |
|
|
2019
Q2 | USD 7.61 M | Comprar |
93,811
+2,139
| +2% | +USD 165 k | ﹤0.01% | 1761 |
|
|
2019
Q1 | USD 6.96 M | Comprar |
91,672
+5,720
| +7% | +USD 454 k | ﹤0.01% | 1811 |
|
|
2018
Q4 | USD 6.74 M | Comprar |
85,952
+783
| +0.9% | +USD 61.3 k | 0.01% | 1718 |
|
|
2018
Q3 | USD 6.42 M | Vender |
85,169
-1,890
| -2% | -USD 139 k | ﹤0.01% | 1909 |
|
|
2018
Q2 | USD 6.13 M | Comprar |
87,059
+8,540
| +11% | +USD 559 k | ﹤0.01% | 1897 |
|
|
2018
Q1 | USD 4.68 M | Comprar |
78,519
+30,122
| +62% | +USD 1.85 M | ﹤0.01% | 1982 |
|
|
2017
Q4 | USD 2.95 M | Comprar |
48,397
+1,325
| +3% | +USD 84.5 k | ﹤0.01% | 2157 |
|
|
2017
Q3 | USD 2.95 M | Comprar |
47,072
+2,229
| +5% | +USD 144 k | ﹤0.01% | 2126 |
|
|
2017
Q2 | USD 3.15 M | Comprar |
44,843
+356
| +0.8% | +USD 25.4 k | ﹤0.01% | 2051 |
|
|
2017
Q1 | USD 3.17 M | Comprar |
44,487
+2,046
| +5% | +USD 151 k | ﹤0.01% | 1999 |
|
|
2016
Q4 | USD 3.22 M | Vender |
42,441
-887
| -2% | -USD 61.5 k | ﹤0.01% | 1954 |
|
|
2016
Q3 | USD 2.86 M | Comprar |
43,328
+4,325
| +11% | +USD 281 k | ﹤0.01% | 1956 |
|
|
2016
Q2 | USD 2.53 M | Vender |
39,003
-7,637
| -16% | -USD 485 k | ﹤0.01% | 1949 |
|
|
2016
Q1 | USD 2.91 M | Comprar |
46,640
+781
| +2% | +USD 48.6 k | ﹤0.01% | 1853 |
|
|
2015
Q4 | USD 2.83 M | Comprar |
45,859
+3,276
| +8% | +USD 212 k | ﹤0.01% | 1891 |
|
|
2015
Q3 | USD 2.59 M | Comprar |
42,583
+1,938
| +5% | +USD 121 k | ﹤0.01% | 1916 |
|
|
2015
Q2 | USD 2.64 M | Vender |
40,645
-1,529
| -4% | -USD 97 k | ﹤0.01% | 1935 |
|
|
2015
Q1 | USD 2.69 M | Comprar |
42,174
+2,682
| +7% | +USD 170 k | ﹤0.01% | 1897 |
|
|
2014
Q4 | USD 2.48 M | Comprar |
39,492
+792
| +2% | +USD 47.6 k | ﹤0.01% | 1889 |
|
|
2014
Q3 | USD 2.15 M | Comprar |
38,700
+479
| +1% | +USD 27.1 k | ﹤0.01% | 1932 |
|
|
2014
Q2 | USD 2.15 M | Vender |
38,221
-50
| -0.1% | -USD 2.72 k | ﹤0.01% | 1947 |
|
|
2014
Q1 | USD 2.14 M | Vender |
38,271
-929
| -2% | -USD 48.7 k | ﹤0.01% | 1923 |
|
|
2013
Q4 | USD 2.11 M | Comprar |
39,200
+2,887
| +8% | +USD 148 k | ﹤0.01% | 1884 |
|
|
2013
Q3 | USD 1.75 M | Comprar |
36,313
+1,068
| +3% | +USD 51 k | ﹤0.01% | 1929 |
|
|
2013
Q2 | USD 1.7 M | Comprar |
+35,245
| Nuevas | +USD 1.65 M | ﹤0.01% | 1856 |
|
Otros fondos que tienen NHC en su cartera
Posición de Charles Schwab en NHC: resumen de T2 2026
Charles Schwab redujo su participación en National Healthcare (NHC) en 2.4% durante T2 2026, al vender acciones por un valor estimado de USD 783 k, y conservó 174,335 acciones valuadas en USD 36.8 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1446.
Charles Schwab reportó por primera vez una posición en NHC en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 248 fondos que sigue Wall St. Rank mantienen una posición en NHC.
- Al cierre de T2 2026, Charles Schwab tenía 174,335 acciones de National Healthcare con un valor de USD 36.8 M.
- Charles Schwab vendió 4,263 acciones de National Healthcare en T2 2026, por un valor estimado de USD 783 k.
- National Healthcare representó ﹤0.01% de la cartera de Charles Schwab en T2 2026 y fue su posición número 1446.
- Charles Schwab reportó por primera vez una posición en National Healthcare en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 248 fondos que sigue Wall St. Rank tenían National Healthcare en cartera.
Según el Informe 13F de Charles Schwab correspondiente a T2 2026, presentado el 14 ago 2026.